Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-26 @ 2:09 AM
Study NCT ID:
NCT00955305
Status:
TERMINATED
Last Update Posted:
2018-06-06
First Post:
2009-08-07
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03
Start Date Type:
None
Primary Completion Date:
2016-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-07
First Submit QC Date:
None
Study First Post Date:
2009-08-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-07-26
Results First Submit QC Date:
None
Results First Post Date:
2016-09-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-03
Last Update Post Date:
2018-06-06
Last Update Post Date Type:
ACTUAL